PTTG: an important target gene for ovarian cancer therapy
2008
PTTG: A Key Gene in Ovarian Cancer Therapy
publication
Evidence: moderate
Author Information
Author(s): Panguluri Siva Kumar, Yeakel Casey, Kakar Sham S
Primary Institution: University of Louisville
Hypothesis
Is PTTG an important target gene for ovarian cancer therapy?
Conclusion
PTTG is highly expressed in various tumors, and its downregulation can suppress tumor growth, suggesting it may be a valuable target for cancer therapy.
Supporting Evidence
- PTTG is overexpressed in many tumors, including ovarian cancer.
- Downregulation of PTTG in tumor cells can suppress tumor growth.
- PTTG plays a role in cell cycle regulation and tumorigenesis.
Takeaway
PTTG is a gene that helps cancer cells grow, and if we can turn it off, we might stop the cancer from getting bigger.
Methodology
The review discusses the role of PTTG in tumor progression and its potential as a target for cancer therapy.
Limitations
The review does not provide experimental data but summarizes existing literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website